Related Experiment Video
Updated: Jul 21, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
[Outcome of arrhythmogenic right ventricular dysplasia. Apropos of 4 cases]
G Fontaine1, C Brestescher, F Fontaliran
1Service de rythmologie et de stimulation cardiaque, hôpital Jean-Rostand, Ivry.
Insights
This study classifies arrhythmogenic right ventricular dysplasia (ARVD) into three types based on left ventricular function and disease progression. Understanding these ARVD types is crucial for predicting patient outcomes and guiding treatment strategies.
Area of Science:
- Cardiology
- Genetics
- Immunology
Background:
- Arrhythmogenic right ventricular dysplasia (ARVD) is a progressive myocardial disease.
- Accurate classification is essential for predicting disease trajectory and patient prognosis.
Observation:
- Type I ARVD: Normal left ventricular ejection fraction (>50%), primarily arrhythmic risk, manageable with antiarrhythmic therapy.
- Type II ARVD: Moderate left ventricular involvement (30% < EF < 50%), stable with arrhythmia management.
- Type III ARVD: Progressive biventricular myocardial degradation over ~10 years, leading to irreversible heart failure and arrhythmic risk, potentially autoimmune.
Findings:
- A novel classification system for ARVD is proposed, correlating with disease progression and left ventricular involvement.
- Histology in Type III ARVD reveals biventricular lymphocytic infiltration and fibrosis, suggesting an autoimmune basis.
- The classification emphasizes the importance of evolutivity and early-stage diagnosis, particularly in hereditary forms.
Implications:
- This classification aids in stratifying ARVD patients based on prognosis and potential for heart failure.
- Early diagnosis and risk stratification are critical, especially for hereditary ARVD cases.
- Understanding the potential autoimmune component in ARVD may open new therapeutic avenues.
Abstract:
The authors propose a classification of the outcome of arrhythmogenic right ventricular dysplasia with reference to 4 selected cases with a follow-up period of over 9 years. In type I, the left ventricular ejection fraction is normal (EF > 50%) and the risk, exclusively arrhythmic, can be controlled by appropriate antiarrhythmic therapy. This is the commonest form of arrhythmogenic right ventricular dysplasia with different varieties according to the degree of dilatation of the right ventricle. In type II, there is a variable degree of left ventricular involvement (30 < EF < 50%) either by extension of a comparable disease process as observed in the right ventricle or by an isolated or superimposed phenomenon of myocarditis. This form is stable and may remain stable for many years providing the arrhythmias are correctly treated. In type III, progressive degradation of the myocardium is observed over a period of about 10 years with a clinical presentation comparable to that of certain arrhythmogenic dilated cardiomyopathies which are often hereditary. In this case, the patients have an arrhythmic risk associated with that of cardiac failure which becomes progressively irreversible. The histology shows interstitial fibrosis with biventricular lymphocytic infiltration suggesting an autoimmune phenomenon. Therefore, the classification of cases of arrhythmogenic right ventricular dysplasia depends on the potential evolutivity of the lesions. When the patient is seen in the early stages of the disease, the prognosis should be garded, especially in a hereditary form.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

